MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. (Q34196069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Clémentine Le Magnen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Paul Zajac

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Luigi Tornillo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Elke Schultz-Thater

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Giandomenica Iezzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Vincenza Carafa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Luigi Terracciano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Giulio C Spagnoli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

12 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1137-1148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710496%20AND%20SRC:MED&resulttype=core&format=json

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

6 February 2020

cites work

1 reference

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies

21 January 2018

1 reference

Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

21 January 2018

1 reference

The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses

21 January 2018

1 reference

Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells

21 January 2018

1 reference

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

21 January 2018

1 reference

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis

21 January 2018

1 reference

MAGE-1 gene product is a cytoplasmic protein.

21 January 2018

1 reference

The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ

21 January 2018

1 reference

Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.

21 January 2018

1 reference

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

21 January 2018

1 reference

Selective cancer-germline gene expression in pediatric brain tumors

21 January 2018

1 reference

Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants

21 January 2018

1 reference

Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines

21 January 2018

1 reference

Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.

21 January 2018

1 reference

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer

21 January 2018

1 reference

Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.

21 January 2018

1 reference

Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering

21 January 2018

1 reference

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

21 January 2018

1 reference

Immunogenic cancer cell death: a key-lock paradigm

21 January 2018

1 reference

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study

21 January 2018

1 reference

Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer

21 January 2018

1 reference

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines

21 January 2018

1 reference

Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo

21 January 2018

1 reference

The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

21 January 2018

1 reference

Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators

21 January 2018

1 reference

Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.

21 January 2018

1 reference

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate.

21 January 2018

1 reference

Aberrant DNA methylation in cutaneous malignancies.

21 January 2018

1 reference

Implications of LINE1 methylation for bladder cancer risk in women

21 January 2018

1 reference

Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability

21 January 2018

1 reference